Jeffrey M. Skolnik

Interim Results of a Phase 1/2 <scp>Open‐Label</scp> Study of <scp>INO</scp>‐3107 for <scp>HPV</scp>‐6 and/or <scp>HPV</scp>‐11‐Associated Recurrent Respiratory Papillomatosis

Ted Mau, Milan R. Amin, Peter C. Belafsky et al. · The Laryngoscope · 2023 · 31 citations · Full text

A sensitive and selective liquid chromatography‐tandem mass spectrometry method for the simultaneous quantification of actinomycin‐D and vincristine in children with cancer

James I. Lee, Jeffrey M. Skolnik, Jeffrey S. Barrett et al. · Journal of Mass Spectrometry · 2007 · 27 citations

CD8+ T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens

Neal D. Shore, Matthew P. Morrow, Trevor McMullan et al. · Molecular Therapy · 2020 · 23 citations · Full text

DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107

Elisabeth Gillespie, Albert J. Sylvester, Milan R. Amin et al. · Nature Communications · 2025 · 13 citations · Full text

Approaches to Clear Residual Chemotherapeutics From Indwelling Catheters in Children With Cancer

Jeffrey M. Skolnik, Alena Y. Zhang, Jeffrey S. Barrett et al. · Therapeutic Drug Monitoring · 2010 · 11 citations · Full text